CROs
Scaling for a New Era: The Rise of Radiopharma
radiopharmaceuticals; radioligand therapy; oncology; precision oncology; targeted alpha therapy; Lutetium-177; Actinium-225; clinical trials; radiotheranostics; M&A; biotech funding; supply chain; infrastructure; CROs; companion diagnostics
Recent Trends in Specialized Support to Accelerate Biotech Success (2025)
biotech support; CROs; advanced therapies; funding; risk management; strategic partnerships; operational efficiency